See more : JPMorgan Claverhouse Investment Trust plc (JCH.L) Income Statement Analysis – Financial Results
Complete financial analysis of Cannassure Therapeutics Ltd (CSURE.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cannassure Therapeutics Ltd, a leading company in the industry within the sector.
- Altiplano Metals Inc. (ALTPF) Income Statement Analysis – Financial Results
- PT Hotel Mandarine Regency Tbk (HOME.JK) Income Statement Analysis – Financial Results
- NorCom Information Technology GmbH & Co. KGaA (NC5A.DE) Income Statement Analysis – Financial Results
- AMAG Austria Metall AG (AMAG.VI) Income Statement Analysis – Financial Results
- Precio Fishbone AB (publ) (PRCO-B.ST) Income Statement Analysis – Financial Results
Cannassure Therapeutics Ltd (CSURE.TA)
Industry: Biotechnology
Sector: Healthcare
About Cannassure Therapeutics Ltd
Cannassure Therapeutics Ltd cultivates and produces medical cannabis. Its products comprise medical cannabis oils, indoor inflorescences, select inflorescences, value inflorescences, and cannavix. The company was founded in 2016 and is based in Ashdod, Israel.
Source: https://incomestatements.info
Category: Stock Reports